Document Detail


GSK3β genetic variability in patients with Multiple Sclerosis.
MedLine Citation:
PMID:  21527318     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Glycogen synthase kinase-3 beta (GSK3β) is a ubiquitous kinase that is part of multiple signaling pathways. It has neurotrophic/neuroprotective effects by mediating the actions of neurotrophic molecules in the brain, thus providing neuroprotection through modulation of energy metabolism. Notably, it has been demonstrated that GSK3β is involved in Wnt-beta-catenin signaling, which contributes to the inhibition of myelination and remyelination processes in mammals. Three-hundred nineteen patients with MS and 294 age-matched controls were genotyped by allelic discrimination for four common GSK3β variants (rs2199503, rs9826659, rs334558 and rs6438552) tagging about 100% of GSK-3β variability. A statistically significant increased frequency of the rs334558 GG genotype was observed in patients as compared with controls (25.4% versus 17.7%, P=0.02; OR:1.58, 95%CI: 1.07-2.34). Stratifying MS patients according to the disease subtype, a statistically significant difference of rs334558 GG frequency was found between Relapsing Remitting (RR), but not Primary Progressive or Secondary MS, and controls (27.0% versus 17.7%, P=0.01; OR: 1.72, 95%CI: 1.13-2.61). GSK3β rs334558 is a susceptibility factor for MS. As it is located in the promoter region, a possible explanatory mechanism could be an influence of the variant on the gene transcription rate.
Authors:
Daniela Galimberti; James Macmurray; Diego Scalabrini; Chiara Fenoglio; Milena De Riz; Cristoforo Comi; David Comings; Francesca Cortini; Chiara Villa; Maria Serpente; Claudia Cantoni; Elisa Ridolfi; Ma-Hin Fardipoor; Maurizio Leone; Francesco Monaco; Nereo Bresolin; Elio Scarpini
Related Documents :
21356868 - Generating hapmap data text reports using the genome browser.
21412948 - Snp uniqueness problem: a proof-of-principle in hapmap snps.
21240498 - Lack of association between plasminogen activator inhibitor type-1 (pai-1) gene 4g/5g p...
18436078 - Novel col4a3 mutations in african american siblings with autosomal recessive alport syn...
11128608 - Parkin as a pathogenic gene for autosomal recessive juvenile parkinsonism.
15135448 - Characterization of microsatellite markers to diagnose adpkd.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-04-17
Journal Detail:
Title:  Neuroscience letters     Volume:  497     ISSN:  1872-7972     ISO Abbreviation:  Neurosci. Lett.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-23     Completed Date:  2011-10-31     Revised Date:  2011-11-02    
Medline Journal Info:
Nlm Unique ID:  7600130     Medline TA:  Neurosci Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  46-8     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Department of Neurological Sciences, "Dino Ferrari" Center, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy. daniela.galimberti@unimi.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Genetic Predisposition to Disease*
Genotype
Glycogen Synthase Kinase 3 / genetics*
Humans
Male
Middle Aged
Multiple Sclerosis / genetics*
Polymorphism, Single Nucleotide
Chemical
Reg. No./Substance:
EC 2.7.11.1/glycogen synthase kinase 3 beta; EC 2.7.11.26/Glycogen Synthase Kinase 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of extracellular calcium concentration on neurite outgrowth in PC12 cells by staurosporine.
Next Document:  Aging-related alterations in the expression and distribution of GluR2 and PICK1 in the rat hippocamp...